OR for complicated disease course
| Variable | OR | 95% CI | P value |
| Univariable analysis | |||
| Male | 2.5 | 0.8 to 8.2 | 0.134 |
| Age, per 5 years | 1.3 | 1.1 to 1.7 | 0.018 |
| Comorbidities (two ore more) | 7.1 | 2.1 to 24.5 | 0.002 |
| Overweight (BMI>25 kg/m2) | 7.2 | 1.9 to 28.3 | 0.004 |
| Cyanotic heart disease/ES | 13.2 | 2.5 to 68.4 | 0.002 |
| Multivariable analysis | |||
| Comorbidities (two or more) | 6.7 | 1.2 to 35.8 | 0.027 |
| Overweight (BMI>25 kg/m2) | 16.4 | 3.2 to 83.4 | 0.001 |
| Cyanotic heart disease/ES | 60.0 | 7.6 to 474.0 | >0.001 |
Among the five patients who died during their hospital stay, COVID-19 related complications and the underlying cardiac defect were considered to interact and contribute to the fatal outcome in four cases. In one case (Patient 3 in table 4), coronavirus infection was considered likely not to be a major contributor to fatal outcome.
BMI, Body Mass Index; ES, Eisenmenger syndrome.